<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04321226</url>
  </required_header>
  <id_info>
    <org_study_id>1422/2017</org_study_id>
    <nct_id>NCT04321226</nct_id>
  </id_info>
  <brief_title>Femtosecond Laser-assisted Astigmatism Treatment</brief_title>
  <acronym>FLAAT</acronym>
  <official_title>Femtosecond Laser-assisted Astigmatism Treatment (FLAAT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigational device is an approved femtosecond laser (FSL) device with an integrated&#xD;
      imaging system to perform certain steps of the cataract procedure including arcuate incisions&#xD;
      (AI) correcting astigmatism, also referred to as arcuate keratotomy (AK). The FSL will&#xD;
      perform anterior capsulotomy and lens fragmentation in individuals suffering from age-related&#xD;
      cataract with need of cataract surgery and additionally perform arcuate keratotomy in&#xD;
      individuals with more than 1.0 Diopter (dpt) of astigmatism. Cataract surgery will be&#xD;
      performed in subjects who have signed an informed consent form.&#xD;
&#xD;
      Postoperative examinations will be implemented in accordance with the approved&#xD;
      Investigational Plan on subjects and includes: postoperative refraction, visual acuity,&#xD;
      slitlamp examination, and corneal topography&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 10, 2017</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 5, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective interventional case series</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal Astigmatism one year after the intervention</measure>
    <time_frame>1 year follow-up</time_frame>
    <description>H0: no change in postoperative refraction astigmatism H1: change in postoperative refraction astigmatism</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Precision and reproducibility of corneal cut depth</measure>
    <time_frame>1 year follow-up</time_frame>
    <description>Corneal Incisions will be measured using an anterior segment SS-OCT</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Age Related Cataracts</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Femtosecond Laser guided Arcuate Keratotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arcuate keratotomy will be performed together with Laser cataract surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond Laser guided Arcuate Keratotomy</intervention_name>
    <description>Astigmatism will be reduced in cataract surgery using a low energy Femtosecond Laser device</description>
    <arm_group_label>Femtosecond Laser guided Arcuate Keratotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age-related cataract necessitating lens extraction and posterior IOL implantation&#xD;
&#xD;
          -  Regular corneal astigmatism between 1.0 and 2.5 DPT&#xD;
&#xD;
          -  Age 40 and older (females of childbearing age will be interviewed if pregnancy is&#xD;
             possible)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Corneal abnormality&#xD;
&#xD;
          -  Preceding ocular surgery or trauma&#xD;
&#xD;
          -  Uncontrolled glaucoma&#xD;
&#xD;
          -  Proliferative diabetic retinopathy&#xD;
&#xD;
          -  Iris neovascularization&#xD;
&#xD;
          -  History of uveitis/iritis&#xD;
&#xD;
          -  Microphthalmus&#xD;
&#xD;
          -  Recurrent intraocular inflammation of unknown etiology&#xD;
&#xD;
          -  Blind fellow eye&#xD;
&#xD;
          -  Uncontrolled systemic or ocular disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Luca Schwarzenbacher, MD</last_name>
    <phone>0140400</phone>
    <phone_ext>79450</phone_ext>
    <email>luca.schwarzenbacher@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rupert Menapace, MD</last_name>
      <phone>+43140400</phone>
      <phone_ext>66300</phone_ext>
      <email>rupert.menapace@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Christina Leydolt, MD</last_name>
      <phone>+43140400</phone>
      <phone_ext>79480</phone_ext>
      <email>christina.leydolt@meduniwien.ac.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>February 23, 2021</last_update_submitted>
  <last_update_submitted_qc>February 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Rupert Menapace</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Laser Cataract Surgery</keyword>
  <keyword>Arcuate Keratotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

